JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES)

Previous Articles     Next Articles

Diagnostic value of aspartate beta-hydroxylase combined with AFP and GP73 for hepatocellular carcinoma

ZHANG Jizong1,2, MENG Jiuda2, DING Hai2, YI Yongxiang2, YU Zeqian3, ZHOU Jiahua3   

  1. 1. School of medicine, Southeast University, Nanjing 210009, Jiangsu, China;
    2. Department of Hepatobiliary Surgery, Second Hospital of Nanjing Affiliated to Southeast University,
    Nanjing 210003, Jiangsu, China;  3. Department of Hepatobiliary Surgery,   Zhongda Hospital
    Affiliated to Southeast University, Nanjing 210009, Jiangsu, China
  • Received:2013-12-16 Online:2014-06-10 Published:2014-06-10

Abstract: Objective  To investigate the diagnostic value of combined detection of serum aspartic acid asparaginebeta hydroxylase (Aspartate Beta-Hydroxylase ASPH), alpha fetoprotein (AFP) and Golgi glycoprotein 73 (GP73) in the diagnosis of primary hepatocellular carcinoma. Methods  The serum AFP, GP73 and ASPH were detected in 50 cases of primary liver cancer, 50 cases of liver cirrhosis and 50 healthy controls to analyze the significance of ASPH combined with AFP and GP73 in the diagnosis of primary hepatocellular carcinoma. Results  In liver cirrhosis group and healthy control group, AFP, GP73 and ASPH were significantly lower than in primary liver cancer group (P<0.05); the sensitivity of AFP, GP73 and ASPH detected alone in the diagnosis of primary hepatocellular carcinoma were 76.00%, 86.00% and 80.00%, respectively; the specificity were 88.00%, 98.00% and 86.00%, respectively; the accuracy was 82.00%, 92.00%, and 87.00% respectively. The sensitivity, specificity and accuracy of GP73 were the highest. Combined detection of AFP, GP73 and ASPH yielded the following Results  : sensitivity (96.00%), specificity (98.00%), accuracy (97.00%), which were higher than parame-ters obtained when AFP, GP73 and ASPH were detected alone. Conclusion  Combined detection of AFP, GP73 and ASPH can improve the diagnosis rate of primary hepatocellular carcinoma and early primary liver cancer.

Key words: Golgi glycoprotein 73, Aspartate beta-hydroxylase, Alpha fetoprotein, Hepatocellular carcinoma

CLC Number: 

  • R735.7
[1] YU De-Xin, CAEI Ti-Gong, MA Xiang-Xing, ZHANG Xiao-Ming, LI Chuan-Fu. Angiogenesis and maturation of hepatocellular carcinoma [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2209, 47(6): 51-54.
[2] SUN Yifeng, GAO Yu, LIANG Yongyuan, GAO Yang. Expression of CPLX2 and its in vitro effects on the proliferation migration and invasion of hepatocellular carcinoma cells [J]. Journal of Shandong University (Health Sciences), 2020, 1(9): 34-39.
[3] WANG Wei, CAO Yushan, SUN Daquan, HUANG Xiaoqiong, XU Guoqiang. Role of human TIMP-2 protein in the migration and invasion of hepatocellular carcinoma cell [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(7): 11-17.
[4] YUE Qianqian, WANG Xinyi, YANG Zhiqiang, JIANG Shu. Quantitative analysis of spectral CT imaging on hypervascular hepatic metastasis and hepatocellular carcinoma [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(7): 50-55.
[5] ZONG Zhaoyun, LI Xia, HAN Zhenlong, WANG Xianteng, GUO Chun, ZHANG Lining, SHI Yongyu. Effect of tumor associated macrophages on the expression of c-Met in hepatocellular carcinoma cells [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(3): 14-18.
[6] SONG Jia, LI Xin, LI Dan, YE Liping. Knockout Grp78 expression increases the sensitivity of hepatoma cells to erlotinib [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(6): 7-12.
[7] GU Xu, WANG Xiaqing, REN Wanhua, QIN Chengyong, HAN Guoqing. Expression and clinical significance of NPRL2 and Survivin in hepatocellular carcinoma [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(6): 68-72.
[8] WANG Hao1, LI Xia2, WANG Chao3, LI Guosheng1, GUO Chun1, ZHU Faliang1, ZHANG Lining1, SHI Yongyu1. Role of tumor-associated macrophages in epithelial-mesenchymal transition of human hepatocellular carcinoma cells [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(4): 8-12.
[9] GUO Weihua, ZHAO Suhong, PANG Guodong, SHAO Guangrui. Application value of diffusion-weighted MR imaging in estimating the histological grade of hepatocellular carcinoma [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(12): 89-93.
[10] LI Heng1, LI Zhe1, QIAO Xiao-jun1, GAO Ai-qin2, ZHANG Nan2. Expressions of centrosome α tubulin, P53 protein and telomerase in hepatocarcinoma and their correlations [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(8): 74-77.
[11] FAN Hai-yan, ZHANG Hui-jing, GUO Zhan-jun, LI Sheng-mian. Prognostic significance of RASSF1A and WIF-1 methylation in the cancer tissues of patients with HCC [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(5): 89-93.
[12] MENG Hai-peng, NIU Wei-bo, WU Xiao-peng, GUO Sen, LIU Yi, CHEN Yu-xin. Effects of type of PVTT on long-term outcomes of  surgical treatment for hepatocellular carcinoma [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(12): 61-66.
[13] CHEN Yuan-hong1, ZENG Yi1, LUO Yan-hong2. Effect of Rabdosia lophanthoides on the proliferation and apoptosis in hepatoma carcinoma cell line HepG2 [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(11): 42-45.
[14] ZHAO Wen-bo1, LIU Xin1, LIU Xiao-qian2, CUI Xin1, WANG Xin1. Isolation of endothelial cells from hepatocellular carcinoma and
their PRL-3 expression
[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(3): 108-112.
[15] XING Qiao-ling1, HAN Zhen-long2, SONG Yong-hong3, GUO Chun1, ZHU Fa-liang1, ZHANG Li-ning1, SHI Yong-yu1. Expression of negative immunoregulatory gene A20 in human
hepatocellular carcinoma  and construction of
its eukaryotic expression vector
[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(12): 19-.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!